Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.22 - $0.5 $20,155 - $45,807
91,615 Added 12.47%
826,089 $247,000
Q4 2022

Feb 13, 2023

BUY
$0.41 - $18.6 $2,453 - $111,302
5,984 Added 0.82%
734,474 $352,000
Q3 2022

Nov 14, 2022

SELL
$0.57 - $34.65 $20,401 - $1.24 Million
-35,792 Reduced 4.68%
728,490 $626,000
Q2 2022

Aug 12, 2022

SELL
$0.85 - $1.41 $416,232 - $690,455
-489,685 Reduced 39.05%
764,282 $714,000
Q1 2022

May 13, 2022

BUY
$1.16 - $2.5 $21,913 - $47,227
18,891 Added 1.53%
1,253,967 $1.66 Million
Q4 2021

Feb 11, 2022

BUY
$2.46 - $8.74 $42,946 - $152,582
17,458 Added 1.43%
1,235,076 $3.04 Million
Q3 2021

Nov 12, 2021

SELL
$5.1 - $9.39 $23,419 - $43,118
-4,592 Reduced 0.38%
1,217,618 $10.4 Million
Q2 2021

Aug 13, 2021

BUY
$3.95 - $6.88 $718,497 - $1.25 Million
181,898 Added 17.48%
1,222,210 $7.82 Million
Q1 2021

May 12, 2021

BUY
$2.01 - $5.55 $999,050 - $2.76 Million
497,040 Added 91.49%
1,040,312 $4.62 Million
Q4 2020

Feb 12, 2021

BUY
$1.73 - $2.13 $261,975 - $322,548
151,431 Added 38.65%
543,272 $1.15 Million
Q3 2020

Nov 13, 2020

BUY
$1.76 - $2.17 $37,746 - $46,539
21,447 Added 5.79%
391,841 $697,000
Q2 2020

Aug 13, 2020

BUY
$1.75 - $2.65 $481,897 - $729,730
275,370 Added 289.79%
370,394 $781,000
Q1 2020

May 14, 2020

BUY
$1.15 - $3.29 $28,242 - $80,799
24,559 Added 34.85%
95,024 $188,000
Q3 2018

Nov 13, 2018

BUY
$1.11 - $1.64 $78,216 - $115,562
70,465 New
70,465 $91,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.